Leith N J, Barrett R J
Psychopharmacology (Berl). 1980;72(1):9-15. doi: 10.1007/BF00433801.
The mood-altering properties of amphetamine (AMPH) in humans (euphoria and depression) have been postulated to be related to the increases and decreases respectively which this drug produces in the sensitivity of the reward system of the brain. The present study further evaluated this relationship by testing the effects of chronic reserpine (RES), another treatment that produces depression in humans, on self-stimulation responding. Separate groups of animals implanted with stimulating electrodes in the medial forebrain bundle were administered daily injections of saline, d-AMPH (5 mg/kg X 7 days followed by 10 mg/kg X 7 days), or RES (0.05 mg/kg X 18 days). At treatment termination, both drug groups showed a significant elevation of the reinforcement threshold, with no recovery occurring during 18 subsequent days. Thus, drug-induced depression of self-stimulation responding may serve as an animal model for studying the underlying physiological basis for clinical depression, or at the very least, for drug-induced depression.
苯丙胺(AMPH)对人类情绪的改变作用(欣快感和抑郁)被假定分别与该药物引起的大脑奖赏系统敏感性的增加和降低有关。本研究通过测试另一种可导致人类抑郁的药物——慢性利血平(RES)对自我刺激反应的影响,进一步评估了这种关系。将分别植入内侧前脑束刺激电极的动物分组,每天注射生理盐水、右旋苯丙胺(5mg/kg,共7天,随后10mg/kg,共7天)或利血平(0.05mg/kg,共18天)。在治疗结束时,两个药物组的强化阈值均显著升高,在随后的18天内未恢复。因此,药物诱导的自我刺激反应抑制可能作为一种动物模型,用于研究临床抑郁症的潜在生理基础,或者至少用于研究药物诱导的抑郁症。